| Q41718283 | 6-bromo-indirubin-3'-oxime (6BIO), a Glycogen synthase kinase-3β inhibitor, activates cytoprotective cellular modules and suppresses cellular senescence-mediated biomolecular damage in human fibroblasts |
| Q38862429 | Atrogin-1 Deficiency Leads to Myopathy and Heart Failure in Zebrafish |
| Q35569092 | Breast cancer cell line MCF7 escapes from G1/S arrest induced by proteasome inhibition through a GSK-3β dependent mechanism. |
| Q34647548 | CYLD deletion triggers nuclear factor-κB-signaling and increases cell death resistance in murine hepatocytes. |
| Q35150882 | Crystal structure of N-{N-[N-acetyl-(S)-leuc-yl]-(S)-leuc-yl}norleucinal (ALLN), an inhibitor of proteasome |
| Q41094657 | Crystal structure of a low molecular weight activator Blm-pep with yeast 20S proteasome - insights into the enzyme activation mechanism |
| Q37087744 | Cycloheximide Chase Analysis of Protein Degradation in Saccharomyces cerevisiae |
| Q39194017 | Dissecting a role of a charge and conformation of Tat2 peptide in allosteric regulation of 20S proteasome. |
| Q37483040 | Genetics of proteasome diseases. |
| Q38177328 | Harnessing proteasome dynamics and allostery in drug design. |
| Q35843506 | Interplay between Structure and Charge as a Key to Allosteric Modulation of Human 20S Proteasome by the Basic Fragment of HIV-1 Tat Protein |
| Q64231716 | Killing Two Angry Birds with One Stone: Autophagy Activation by Inhibiting Calpains in Neurodegenerative Diseases and Beyond |
| Q58772499 | Loss of the novel Vcp (valosin containing protein) interactor Washc4 interferes with autophagy-mediated proteostasis in striated muscle and leads to myopathy in vivo |
| Q38219604 | Melatonin and ubiquitin: what's the connection? |
| Q50212589 | Nanoparticles Exacerbate Both Ubiquitin and Heat Shock Protein Expressions in Spinal Cord Injury: Neuroprotective Effects of the Proteasome Inhibitor Carfilzomib and the Antioxidant Compound H-290/51. |
| Q93210381 | Proline- and Arginine-Rich Peptides as Flexible Allosteric Modulators of Human Proteasome Activity |
| Q92454652 | Proteasome Activation to Combat Proteotoxicity |
| Q48451321 | Systemic Proteasome Inhibition Induces Sustained Post-stroke Neurological Recovery and Neuroprotection via Mechanisms Involving Reversal of Peripheral Immunosuppression and Preservation of Blood-Brain-Barrier Integrity |
| Q33417942 | T cell immune abnormalities in immune thrombocytopenia |
| Q26785503 | The different roles of selective autophagic protein degradation in mammalian cells |
| Q34602263 | The potential of panobinostat as a treatment option in patients with relapsed and refractory multiple myeloma |
| Q47672665 | β-Amyloid and the Pathomechanisms of Alzheimer's Disease: A Comprehensive View |